Athelas is built on deep learning technology that uses vision to rapidly analyze blood cells and generate diagnostic reports. Because we utilize machine vision instead of traditional coulter counting or flow based techniques we're able to maintain a high degree of precision on drop samples; performing with greater accuracy than other existing tech.
Our team is comprised of deep learning and biotech researchers, mechanical engineers, and medical advisors. We have an inherent focus on bringing cutting edge techniques into the hands of consumers.
Blood Cell counts enable rapid analysis of a patient's immune and hematological conditions. Our first product allows immunocompromised patients to monitor their White Blood Cell counts at home to better determine when necessary to visit a doctor. WBCs offer unique insight as to this - indicating anything from inflammatory response, all the way to Leukemia.